Literature DB >> 4311187

Intermittent corticotrophin treatment: ventilatory tests in asthmatic subjects.

R C Lowry, J S Mackay, B Sheridan, J A Weaver.   

Abstract

Ventilatory tests (F.E.V.(1)/F.V.C.) have been studied in 16 asthmatic subjects during intermittent administration of corticotrophin, and the responses correlated with the plasma cortisol levels. The improvement in respiratory function was found to last for a longer period than the enhanced adrenocortical activity.

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4311187      PMCID： PMC1630554          DOI： 10.1136/bmj.4.5681.455

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  7 in total

1.  STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN.

Authors:  J G HARTER; W J REDDY; G W THORN
Journal:  N Engl J Med       Date:  1963-09-19       Impact factor: 91.245

2.  A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma.

Authors:  D MATTINGLY
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

3.  Intermittent therapy with corticotrophin.

Authors:  J K Nelson; J S Mackay; B Sheridan; J A Weaver
Journal:  Lancet       Date:  1966-07-09       Impact factor: 79.321

4.  Hypothalamo-pituitary-adrenal function in patients on long-term adrenocorticotrophin therapy.

Authors:  P A Bacon; J R Daly; A B Myles; O Savage
Journal:  Ann Rheum Dis       Date:  1968-01       Impact factor: 19.103

5.  Airways obstruction before and after isoprenaline, histamine, and presnisolone in patients with chronic obstructive bronchitis.

Authors:  E A Oppenheimer; M Rigatto; C M Fletcher
Journal:  Lancet       Date:  1968-03-16       Impact factor: 79.321

6.  Corticosteroids in treatment of chronic asthma.

Authors:  S D Walsh; I W Grant
Journal:  Br Med J       Date:  1966-10-01

7.  Suppression of 17-hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinolone.

Authors:  S D Grant; P H Forsham; V C DiRaimondo
Journal:  N Engl J Med       Date:  1965-11-18       Impact factor: 91.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.